Activity value 80india Buyer&Supplier,Last transaction date:
2026-03-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for symbolife pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 196 transactions, with a transaction quantity of 48961 and a transaction weight of 100.
Product description
(2) FEXOFENADINE HCL USP MFG DATE DEC-2025 & EXP DATE NOV-2030 BATCH NO. FFX18725 QUANTITY TOTAL NET WEIGHT 25-KGS ORIGIN INDIA.
Expand
Product description
(3) ESCITALOPRAM OXALATE IP/IH MFG DATE JAN-2026 & EXP DATE DEC-2030 BATCH NO. MC-005/26 QUANTITY TOTAL NET WEIGHT 25-KGS ORIGIN INDIA
Expand
Product description
(1) OLANZAPINE USP MFG DATE OCT-2025 & EXP DATE SEP-2030 BATCH NO. NOPH2512018 QUANTITY TOTAL NET WEIGHT 10-KGS ORIGIN INDIA
Expand
symbolife pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as gin,pharmaceutical raw material,pharmaceutical ingredient.
According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 4326 international trades,
with its main trading regions covering pakistan,colombia,vietnam etc.
The core products include HS29339990,HS29420090,HS29333990 etc,
often transported via mumbai (ex bombay),port bombay air, port jnpt etc,
and its main trading partners are habib metropolitan,.to the order of bank al habib,to the ordr of meezan bank ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on symbolife pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.